MISSION WEALTH MANAGEMENT, LP

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1645382 Santa Barbara, CA

Position in REGN

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$846,143

+$423,509 QoQ

Shares Held

1,357

+148.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#676

of 1,322 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

MISSION WEALTH MANAGEMENT, LP holds $7,414,287 across 8 Biotechnology names. REGN ranks #2 (11.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	8,170	$4,058,284
2	REGN	Regeneron Pharmaceuticals, Inc. This page	1,357	$846,143
3	EXEL	Exelixis, Inc.	12,301	$669,297
4	INCY	Incyte Corp	4,772	$540,953
5	GPCR	Structure Therapeutics Inc.	7,583	$406,979
6	CPRX	Catalyst Pharmaceuticals, Inc.	11,202	$352,078
7	BMRN	Biomarin Pharmaceutical Inc	5,739	$328,385
8	RPRX	Royalty Pharma plc	3,784	$212,168

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$846,143	1,357	+148.1%	Shares	Sole	2026-07-20
2026-03-31	$422,634	547	-7.1%	Shares	Sole	2026-05-15
2025-12-31	$454,631	589	-12.1%	Shares	Sole	2026-02-05
2025-09-30	$376,720	670	-10.8%	Shares	Sole	2025-11-04
2025-06-30	$394,275	751	-4.5%	Shares	Sole	2025-08-05
2025-03-31	$498,504	786	+47.7%	Shares	Sole	2025-04-17
2024-12-31	$378,959	532	-77.2%	Shares	Sole	2025-02-06
2024-09-30	$2,455,696	2,336	+21.2%	Shares	Sole	2024-10-31
2024-06-30	$2,025,334	1,927	+4.2%	Shares	Sole	2024-08-05
2024-03-31	$1,780,606	1,850	+292.8%	Shares	Sole	2024-04-30
2023-12-31	$413,674	471	+4.2%	Shares	Sole	2024-02-05
2023-09-30	$371,977	452	0.0%	Shares	Sole	2023-10-24
2023-06-30	$324,780	452	+3.9%	Shares	Sole	2023-08-04
2023-03-31	$357,426	435	+3.6%	Shares	Sole	2023-04-07
2022-12-31	$303,025	420	—	Shares	Sole	2023-02-02
No filing history on record for this holder in this stock.